-transparent.png){kind=logo}
Acute hepatotoxicity after administration of 10-1000 mg/kg methotrexate (MTX) to rats was studied by monitoring serum transaminases, liver morphology, and disposition kinetics of MTX and 7-hydroxy-methotrexate (7-OH-MTX). Half the control rats and rats administered 1000 mg/kg MTX, had their bile duct cannulated. One to 2 hr after administration of 1000 mg/kg MTX, 50% of MTX treated bile-drained rats (Ebc) developed cholestasis despite similar or larger initial bile flow rates than those which did not develop cholestasis (Ebn, controls). In Ebc animals, peak serum ASAT and ALAT levels were 6- and 4-fold higher than that of the control rats, and morphologically, prominent hepatocytic changes and grossly dilated bile canaliculi were found. Immediately prior to cholestasis, the Ebc animals reached biliary 7-OH-MTX levels (8.3 +/- 1.3 mM, mean +/- S.E.M.) which were equivalent to the threshold level for precipitation of 7-OH-MTX in rat bile in vitro, and 3-fold higher than the corresponding levels of 7-OH-MTX in the bile of Ebn rats. Ninety-five % of the drug in the precipitated material was 7-OH-MTX. Hence, 7-OH-MTX may play a role in acute MTX hepatotoxicity, a dose-limiting toxicity that may not be counteracted by leukovorin rescue.
R M Bremnes, and
E Smeland, and
N E Huseby, and
T J Eide, and
J Aarbakke
January 1987,
NCI monographs : a publication of the National Cancer Institute,
R M Bremnes, and
E Smeland, and
N E Huseby, and
T J Eide, and
J Aarbakke
July 1983,
Archives of dermatology,
R M Bremnes, and
E Smeland, and
N E Huseby, and
T J Eide, and
J Aarbakke
November 1988,
Human toxicology,
R M Bremnes, and
E Smeland, and
N E Huseby, and
T J Eide, and
J Aarbakke
January 2005,
Medical principles and practice : international journal of the Kuwait University, Health Science Centre,
R M Bremnes, and
E Smeland, and
N E Huseby, and
T J Eide, and
J Aarbakke
March 2008,
Pediatric hematology and oncology,
R M Bremnes, and
E Smeland, and
N E Huseby, and
T J Eide, and
J Aarbakke
December 1979,
Onkologie,
R M Bremnes, and
E Smeland, and
N E Huseby, and
T J Eide, and
J Aarbakke
September 2009,
Anales de pediatria (Barcelona, Spain : 2003),
R M Bremnes, and
E Smeland, and
N E Huseby, and
T J Eide, and
J Aarbakke
February 1992,
The Medical journal of Australia,
R M Bremnes, and
E Smeland, and
N E Huseby, and
T J Eide, and
J Aarbakke
January 1982,
Cancer chemotherapy and pharmacology,
R M Bremnes, and
E Smeland, and
N E Huseby, and
T J Eide, and
J Aarbakke
January 2018,
Cureus,
